Research showed that “a combination of two currently licensed agents was able to significantly inhibit virus replication and tissue damage by the MERS coronavirus in human bronchus and lung."
The National IHR Focal Point of the United Arab Emirates has reported one laboratory-confirmed case of Middle East Respiratory Syndrome (MERS) infection to the World Health Organization (WHO).
Research findings indicate a lower MERS-CoV seropositivity among Israeli dromedaries than in the surrounding countries, and for the first time naturally infected llamas were identified.
This resource provides concise and up-to-date knowledge on 15 infectious diseases that have the potential to become international threats, and tips on how to respond to each of them.
A 2015 outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) in Jordan involved a variant virus that acquired distinctive deletions in the accessory open reading frames.
Up to 50 percent of Middle East respiratory syndrome coronavirus (MERS-CoV) cases in Saudi Arabia have been classified as secondary, occurring from human-to-human transmission through contact with asymptomatic or symptomatic MERS-CoV infected individuals.
Researchers discuss a patient who became a Middle East respiratory syndrome coronavirus (MERS-CoV) superspreader, igniting a multi-hospital outbreak.
Middle East respiratory syndrome coronavirus (MERS-CoV) causes frequent hospital outbreaks in Saudi Arabia with emergency departments as the initial site of virus spread.
Investigations into Middle East respiratory syndrome (MERS) cases detected in hospitals should test broadly for potential contacts.
Researchers used the full details of MERS-CoV cases available on the disease outbreak news section of the World Health Organization website to extract demographic and clinical information, global distribution, contacts, and probable risk factors for the mortality of laboratory-confirmed MERS-CoV cases for analysis.